Table 3.
Univariate and multivariate Cox analyses of the overall survival of patients with NSCLC. Cox analysis was performed on the effect of single factors, such as age, gender, and tissue type, on the survival rate of the patients with NSCLC. Statistically significant variables, namely, clinical staging, lymph node metastasis, degree of differentiation, and miR-92a expression, in the univariate Cox analysis were included in the multivariate Cox regression analysis.
Variable | Univariate Cox analysis HR (95% CI) | P value | Multivariate Cox analysis HR (95% CI) | P value |
---|---|---|---|---|
Age (yr) | ||||
<60 | 1.3 (0.74–2.6) | .682 | – | – |
≥60 | ||||
Gender | ||||
Male | 1.4 (0.87–2.48) | .213 | – | – |
Female | ||||
Smoking history | ||||
Yes | 0.97 (0.59–1.68) | .758 | – | – |
No | ||||
Organization type | ||||
Squamous cell carcinoma | 1.1 (0.72–1.83) | .327 | – | – |
Adenocarcinoma | ||||
Clinical staging | ||||
I/II | 2.2 (1.2–2.91) | .009 | 0.96 (0.53–2.7) | .869 |
III/IV | ||||
Lymph node metastasis | ||||
No | 4.5 (2.4–8.5) | <.001 | 4.0 (2.1–7.7) | <.001 |
Yes | ||||
Distant metastasis | ||||
No | 2.2 (1.0–4.6) | .0435 | 1.3 (0.61–2.5) | .792 |
Yes | ||||
Differentiation | ||||
Highly and moderately differentiated | 2.5 (1.5–4.8) | .0472 | 1.6 (0.87–2.7) | .316 |
Poorly differentiated | ||||
Tumor size | ||||
≥3 cm | 1.7 (0.87–2.39) | .219 | – | – |
<3 cm | ||||
Expression of miR–92a | ||||
High expression | 2.4 (1.2–4.3) | .003 | 1.8 (1.0–3.2) | .036 |
Low expression |
NSCLC = non-small cell lung cancer.